Apixaban Market

Key Players

  • 1A Pharma
  • Accord Healthcare
  • Accord Healthcare France
  • Alivus Life Sciences
  • Aristo Pharma
  • Aurobindo Pharma / Apitoria
  • Biogaran
  • Bristol Myers Squibb France
  • Bristol Myers Squibb Japan
  • Bristol Myers Squibb UK
  • CDMO
  • CDMO formulation
  • CDMO-linked
  • CDMO-linked sourcing
  • CSPC Pharmaceutical Group
  • Celltrion Pharm
  • Chong Kun Dang
  • DMF-linked
  • Daewoong Pharmaceutical
  • Daiichi Sankyo Espha Co. Ltd
  • Direct API
  • Direct API contracts
  • Distributor
  • Distributor-backed generic
  • Dong-A ST
  • Dossier-support partnerships
  • Dr. Reddy’s Laboratories
  • East Asian API
  • Export distributors
  • Finished-dose Players
  • Hanmi Pharmaceutical
  • Hetero Drugs
  • Hexal / Sandoz
  • Hospital-linked generic
  • Indian API Leaders
  • JW Pharmaceutical
  • Jiangsu Hengrui Medicine
  • Laurus Labs
  • MSN Laboratories
  • Meiji Seika Pharma
  • Mylan UK
  • NHS-linked generic
  • Nanjing Triastek
  • Nichi-Iko Pharmaceutical
  • Optimus Drugs
  • Pfizer Japan Inc
  • Qilu Pharmaceutical
  • Ratiopharm / Teva Germany
  • STADA
  • STADA Arzneimittel
  • Sales & Marketing Channels
  • Sandoz
  • Sandoz France
  • Sawai Pharmaceutical
  • Teva
  • Teva Santé
  • Teva UK
  • Towa Pharmaceutical
  • Viatris Inc
  • Viatris Germany
  • Viatris Santé
  • Viatris UK
  • Yuhan Corporation
  • Zentiva
  • Zentiva France
  • Zentiva Pharma Germany
  • Zentiva UK
  • Zhejiang Charioteer Pharmaceutical
  • Zhejiang Hisun Pharmaceutical Co. Ltd
  • Zhejiang Huahai Pharmaceutical
  • Zydus Lifesciences Ltd
Future Market Insights

Apixaban Market